Unfavorable social determinants of health and risk of mortality in adults with diabetes: findings from the National Health Interview SurveyRyan Chang, Jerrin Philip, Umair Javed, Anoop Titus, Syed Karam Gardezi, Harun Kundi, Raman Yousefzai, Adnan A Hyder, Elias Mossialos, Khurram Nasir, Zulqarnain Javed
30 January 2024
Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare recordsWilliam Doran, Louis Tunnicliffe, Rutendo Muzambi, Christopher T Rentsch, Krishnan Bhaskaran, Liam Smeeth, Carol Brayne, Dylan M Williams, Nish Chaturvedi, Sophie V Eastwood, Susanna J Dunachie, Rohini Mathur, Charlotte Warren-Gash
25 January 2024
Diabetes and chronic kidney disease in Chinese adults: a population-based cohort studyXue Wang, Lu Chen, Kexiang Shi, Jun Lv, Dianjianyi Sun, Pei Pei, Ling Yang, Yiping Chen, Huaidong Du, Jiaqiu Liu, Xiaoming Yang, Maxim Barnard, Junshi Chen, Zhengming Chen, Liming LiSee the full list of authors
24 January 2024
Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study)Gergő A Molnár, Zoltán Vokó, Gábor Sütő, György Rokszin, Dávid Nagy, György Surján, Orsolya Surján, Péter Nagy, István Kenessey, András Wéber, Mihály Pálosi, Cecília Müller, Miklós Kásler, István Wittmann, Zoltan Kiss
24 January 2024
Should insulin resistance (HOMA-IR), insulin secretion (HOMA-β), and visceral fat area be considered for improving the performance of diabetes risk prediction modelsHuan Hu, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Tetsuya Mizoue
8 January 2024
High prevalence of retinopathy in young-onset type 2 diabetes and possible sex differences: insights from Norwegian general practiceKatrina Tibballs, Anne Karen Jenum, Lars Kirkebøen, Tore Julsrud Berg, Tor Claudi, John Graham Cooper, Kjersti Nøkleby, Sverre Sandberg, Jørund Straand, Esben Selmer Buhl
2 January 2024
Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitisAnastasia-Stefania Alexopoulos, Alice Parish, Maren Olsen, Bryan C Batch, Cynthia Moylan, Matthew J Crowley
29 November 2023
Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort studyRicheek Pradhan, Oriana H Y Yu, Robert W Platt, Laurent Azoulay
10 November 2023
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort studyAbraham Olvera-Barrios, Christopher G Owen, John Anderson, Alasdair N Warwick, Ryan Chambers, Louis Bolter, Yue Wu, Roshan Welikala, Jiri Fajtl, Sarah A Barman, Paolo Remagnino, Emily Y Chew, Frederick L Ferris, Aroon D Hingorani, Reecha SofatSee the full list of authors
10 November 2023
Medical expenditure trajectory and HbA1c progression prior to and after clinical diagnosis of type 2 diabetes in a commercially insured population in the USALorissa Pagán, Wenya Yang, Hui Shao, Yu Wang, Ping Zhang
1 November 2023